Background: Non-ST elevation myocardial infarction (NSTEMI) patients like other patients with acute coronary syndrome (ACS) need assessment of severity of coronary artery disease (CAD) for prognostication and management. The available scoring systems are complex and include invasive parameters. On the other hand, potassium is a key element and its blood level has been shown to reflect health and disease of vasculature including in some ACS. Objective: The study was conducted to find out the relationship between serum potassium level and angiographic severity of CAD in NSTEMI. Method: A total of 200 cases of NSTEMI patients undergoing coronary angiography (CAG) were included. Patients getting medications that alter potassium homeostasis (e.g., diuretics, glucocorticoids, intravenous insulin), having renal impairment, haematological or liver disease, congenital or valvular heart disease, cardiomyopathy, prior percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) were excluded. Serum potassium was measured soon after admission with NSTEMI, and the patients were divided: mid to high normal (4 to 5.5 mmol/L) constituted the group I and low normal (3.5-3.9 mmol/L) constituted the group II. CAG was done during index admission, SYNTAX score calculated and compared between 2 groups. Results: High SYNTAX score was significantly more commonly found in group I than in group II (62.1% vs. 14.7%, p<0.001). Mean SYNTAX score was higher in group I than in group II (24.3±8.2 vs. 15.3±7.8, p<0.001). There was a linear relationship between serum potassium level and SYNTAX score. Mid to high normal serum potassium, hypertension and dyslipidemia were found to be significantly related to higher SYNTAX score with odds ratio being 10.44, 4.37 and 2.12 respectively. Conclusions: Within physiological limits, higher serum potassium level correlates with severe coronary artery disease in NSTEMI patients. It may be used as an additional tool in conjunction with other scoring systems to assess the severity of CAD in this subset of ACS patients. Bangladesh Heart Journal 2020; 35(2) : 128-133
Introduction: Population demography of the world including Bangladesh is on transition. The increasing number of elderly persons has a direct impact on the demand for health services due to the consequent rise in degenerative diseases of aging and changing life style. The chief objective was to know the median age of the medical inpatients.Methods: This was an observational study. It was conducted in the wards of Medicine department of Dhaka Medical College Hospital from the 1st of March to 15th March.Result: Median age of the admitted patients is 44.5 years. Highest admission is from the 6th to 8th decade of age group. A total of 176 patients (31.88%) were above the ageof 60 years.Discussion: Median age is one of the important measures of population aging. Global median age is 29 years whereas median age of Bangladeshi population is 22 years. The medianage of medical inpatients is relatively high. Percentage of patients aged more than 50 years are doubled in two decades.Conclusion: It is evident that the face of patients in medicine wards is growing older. We must redistribute our resources to deal the conditions and diseases prevalent to the elderly people. We must be kept our preparedness up to date to serve the senior citizens.J MEDICINE January 2016; 17 (1) : 27-29
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.